TY - JOUR
T1 - Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease
AU - Bezzio, Cristina
AU - Franchellucci, Gianluca
AU - Savarino, Edoardo V
AU - Mastronardi, Mauro
AU - Caprioli, Flavio Andrea
AU - Bodini, Giorgia
AU - Variola, Angela
AU - Scaldaferri, Franco
AU - Furfaro, Federica
AU - Calabrese, Emma
AU - Principi, Maria Beatrice
AU - Biscaglia, Giuseppe
AU - Marzo, Manuela
AU - Michielan, Andrea
AU - Cavalli, Carolina
AU - Aratari, Annalisa
AU - Campigotto, Michele
AU - Ceccarelli, Linda
AU - Cappello, Maria
AU - Saibeni, Simone
AU - Balestrieri, Paola
AU - Soriano, Alessandra
AU - Casini, Valentina
AU - Bertani, Lorenzo
AU - Barberio, Brigida
AU - Conforti, Francesco Simone
AU - Danese, Silvio
AU - Armuzzi, Alessandro
PY - 2024
Y1 - 2024
N2 - Upadacitinib has recently been approved for treating Crohn's disease (CD). Here, we report on the effectiveness and safety of upadacitinib in a cohort of patients with diffcult-to-treat CD being cared for at clinical centers across Italy.
AB - Upadacitinib has recently been approved for treating Crohn's disease (CD). Here, we report on the effectiveness and safety of upadacitinib in a cohort of patients with diffcult-to-treat CD being cared for at clinical centers across Italy.
KW - Crohn’s disease
KW - difficult-to-treat IBD
KW - effectiveness
KW - remission
KW - response
KW - upadacitinib
KW - Crohn’s disease
KW - difficult-to-treat IBD
KW - effectiveness
KW - remission
KW - response
KW - upadacitinib
UR - https://publicatt.unicatt.it/handle/10807/312372
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85209736661&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85209736661&origin=inward
U2 - 10.1093/crocol/otae060
DO - 10.1093/crocol/otae060
M3 - Article
SN - 2631-827X
VL - 6
SP - N/A-N/A
JO - CROHN’S & COLITIS 360
JF - CROHN’S & COLITIS 360
IS - 4
ER -
